Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
about
Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.The role of epoxyeicosatrienoic acids in the cardiovascular systemSoluble epoxide hydrolase: A potential target for metabolic diseasesCyclooxygenase- and cytochrome P450-derived eicosanoids in strokeSoluble epoxide hydrolase: gene structure, expression and deletionStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerA dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty ratAdenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγRenal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceAssociation of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgeryBeneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse modelEpoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury.Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy.CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.High salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels.Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats.Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity.Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGFβ3 expression contributes to the delay of epithelial wound healing in diabetic corneas.Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.Endothelial dysfunction and vascular disease - a 30th anniversary update.Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms.The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.Development of Ecom₅₀ and retention index models for nontargeted metabolomics: identification of 1,3-dicyclohexylurea in human serum by HPLC/mass spectrometryRole of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.Inhibition of Soluble Epoxide Hydrolase 2 Ameliorates Diabetic Keratopathy and Impaired Wound Healing in Mouse Corneas.Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2 Diabetic Patients.Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury.
P2860
Q27334040-CD7B64FA-2FC7-46D6-BEAD-FFDE55284863Q28256560-DAAD1908-22E1-4A7F-AA97-E8ED51813E08Q28270454-ECABF607-F89C-4304-9EE3-1D58DE492951Q28271874-502A3FC6-999C-4B28-8D4A-D5F5B2722A22Q28291292-EB12BDF6-119F-4325-A2FD-187FDBD2D734Q28304230-70FAB5D7-03CB-4D2C-A791-13D800D41833Q28390006-D712B1D3-3EA8-4B5B-9F8A-523C5B7063B1Q28392991-94A37D52-D11C-497D-8D14-F8530DE67605Q28398028-B3385D10-4E51-4031-927B-16F1D210C26EQ33731887-F3343B2A-04F3-4A74-970C-372D6E43F99FQ33738489-00D138C1-BC20-4E37-B9C4-048E6F45F892Q34229608-63116F4B-7F49-493B-8007-8B8177D81D4DQ34355908-216E6D66-A0AD-4C6D-A163-11FB54B410A4Q35061561-509DBB71-9B8B-4CE3-92BF-7A21F9B0E025Q35086490-E540962C-A891-468F-ACD7-55F02F5BD712Q35115765-50F11DA7-F0EC-4F0E-9B2A-CD67F2E7F497Q35751044-24F534C1-EA01-4337-8B3B-8729A13FA7BDQ35821566-F8F67E5B-34FD-46BE-80FA-5C82AE30A40DQ36074329-EDB0CE1A-1D0E-466E-A90E-8C020F1D2026Q36731626-22FB19BC-1A2F-47B5-AA32-9D17BB495FAFQ37022931-E7CF0E22-020F-4E1C-AABA-DC7277DCF88FQ37414424-46E126A1-F9DE-4EEC-850D-A2ED5BD5AB45Q37510195-EAF0F1E7-7E17-47DE-A1E9-80132E85947DQ37960812-2923E0DD-EB77-458A-ABD7-C5035C735C7DQ38083851-A5D5EA5D-2117-4A09-9C3E-005510614B62Q38184587-A5BE2E8E-0D4C-4623-A2F4-90EA1A00457AQ38652820-D43CF8F8-CEDE-4389-9ADE-E2C02986D455Q38680112-D53BCEF8-8157-4E7C-92C0-EF0FB9F23A9FQ38993712-D1F69FF1-3758-40A3-B8D2-73F7CE744F3FQ39644067-C3CC4C90-0D2A-4F01-A98D-241D7B886B9AQ42202750-923809BA-B996-4C85-9702-FC7D3B4E4249Q42711742-F0130F5B-BB89-411A-A1EF-315DD47BF84BQ45990632-FA417E19-3AE3-4155-824C-1A2CA82061C6Q46411006-174D2F0A-4513-4B23-80CF-0C328D755ED6Q52609150-BFEDCFF2-3D85-4C17-BF34-1BB9D547AF2BQ52614385-90E9C04D-CE7D-4A51-9306-842378E685E7Q52707785-05598070-BEB0-421D-83FB-A38AF4F59D4BQ55248474-8C75CE2E-672C-44E0-9334-2F9A47E5FD00Q55324500-4F6D5703-0E8B-4B2C-8582-F042EA39DE6D
P2860
Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Deletion of soluble epoxide hy ...... tocin-induced type 1 diabetes.
@ast
Deletion of soluble epoxide hy ...... tocin-induced type 1 diabetes.
@en
type
label
Deletion of soluble epoxide hy ...... tocin-induced type 1 diabetes.
@ast
Deletion of soluble epoxide hy ...... tocin-induced type 1 diabetes.
@en
prefLabel
Deletion of soluble epoxide hy ...... tocin-induced type 1 diabetes.
@ast
Deletion of soluble epoxide hy ...... tocin-induced type 1 diabetes.
@en
P2093
P2860
P50
P1476
Deletion of soluble epoxide hy ...... otocin-induced type 1 diabetes
@en
P2093
Ahmed A Elmarakby
Jessica Faulkner
Mong-Heng Wang
P2860
P304
P356
10.1152/AJPREGU.00759.2010
P577
2011-08-10T00:00:00Z